E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression. Wang et al.

Published: 21 January 2022| Version 1 | DOI: 10.17632/gdcgx46ht8.1
Contributor:
Ying Liu

Description

This is the original data set for our study entitled "E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression"

Files

Institutions

  • Peking University

Categories

Life Sciences, Mammalian Target of Rapamycin, Ubiquitylation

Licence